Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H22N2O3 |
Molecular Weight | 290.3575 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@H](NC(C)C)[C@@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2
InChI
InChIKey=FKNXQNWAXFXVNW-WBMJQRKESA-N
InChI=1S/C16H22N2O3/c1-4-12(17-9(2)3)16(21)11-5-7-13(19)15-10(11)6-8-14(20)18-15/h5-9,12,16-17,19,21H,4H2,1-3H3,(H,18,20)/t12-,16+/m1/s1
Molecular Formula | C16H22N2O3 |
Molecular Weight | 290.3575 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.drugbank.ca/drugs/DB01366Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/894683
Sources: https://www.drugbank.ca/drugs/DB01366
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/894683
Procaterol is a beta2-adrenoreceptor agonist. It is a bronchodilator that may be administered orally or by aerosol inhalation for the treatment of dyspnea caused by bronchial asthma, chronic bronchitis, and pulmonary emphysema. The drug is not approved in the USA, but is available in Japan, Indonesia, and other countries worldwide.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P07550|||Q53GA6|||Q9UCZ3 Gene ID: 154.0 Gene Symbol: ADRB2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/894683 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | MEPTIN Approved UseFor the treatment of dyspnea caused by bronchial asthma, chronic bronchitis, and pulmonary emphysema |
|||
Primary | MEPTIN Approved UseFor the treatment of dyspnea caused by bronchial asthma, chronic bronchitis, and pulmonary emphysema. |
|||
Primary | MEPTIN Approved UseFor the treatment of dyspnea caused by bronchial asthma, chronic bronchitis, and pulmonary emphysema. |
PubMed
Title | Date | PubMed |
---|---|---|
Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study. | 1985 Oct |
|
A comparison of oral procaterol and albuterol in reversible airflow obstruction. | 1988 Dec |
|
Beta 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys. | 1997 Feb |
|
Beta2-adrenoceptors on the glial cells mediate the induction of interleukin-1beta mRNA in the rat brain. | 1997 Oct 3 |
|
The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. | 2010 Jul |
Patents
Sample Use Guides
Meptin tablets: the usual adult dose is 50 µg (one tablet) once before bed or twice daily (in the morning and before bed) by the oral route. Meptin air: in general, for adults, inhale 2 puffs (20 mcg of active ingredient) at a time, and for children, inhale 1 puff (10 mcg of active ingredient) at a time. The dosage may be adjusted according to your disease, age, or symptoms. Strictly follow the instructed dosing schedule. The maximum dosage is restricted to 4 times daily (8 puffs for adults and 4 puffs for children).
Route of Administration:
Other
To study the beta2-blocking activity of procaterol, a guinea pig tracheal test was performed. The trachea was excised from male guinea pigs. A spiral section of the trachea was prepared and suspended in a 30-ml tissue bath. The condition of the tracheal muscle was monitored by isometric recordings using force transducers. Phentolamine was added to the bath fluid 15 min before induction of contraction with the test compound to block alpha-adrenergic receptors. ED50 for procaterol was 11 nM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:36:03 GMT 2023
by
admin
on
Fri Dec 15 18:36:03 GMT 2023
|
Record UNII |
X7I3EMM5K0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QR03AC16
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
||
|
WHO-ATC |
R03CC08
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
||
|
WHO-ATC |
R03AC16
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
||
|
WHO-VATC |
QR03CC08
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB10058MIG
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
CHEMBL160519
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
2273
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
276-590-0
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
100000081133
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
m9147
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | Merck Index | ||
|
3464
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
4259
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
688563
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
72332-33-3
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
DB01366
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
C170351
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
34530
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | RxNorm | ||
|
D017265
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
DTXSID5045673
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
X7I3EMM5K0
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY | |||
|
PROCATEROL
Created by
admin on Fri Dec 15 18:36:03 GMT 2023 , Edited by admin on Fri Dec 15 18:36:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
SHORT-ACTING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |